ArticleVeterinary world2025
Characterization of immunosuppression of genotype A2dB1 variant infectious bursal disease virus isolated in Malaysia using specific pathogen-free and commercial broiler chickens.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Infectious bursal disease (IBD) is an immunosuppressive disease caused by the IBD virus (IBDV), which adversely affects poultry vaccination programs. The novel variant IBDV (nvIBDV) has recently emerged in various regions, including Malaysia, raising concerns about its immunosuppressive potential and impact on Newcastle disease (ND) vaccination. This study aimed to investigate the immunosuppressive effects of the Malaysian nvIBDV strain (UPM1432/2019) in specific-pathogen-free (SPF) and broiler chickens and evaluate its influence on ND vaccine efficacy. Materials and Methods: SPF chickens were orally infected with nvIBDV across three passage levels to study virus-induced clinical signs, lesions, and atrophy. Broiler chickens were vaccinated with live and killed ND vaccines and subsequently challenged with nvIBDV to measure ND antibody titers. The genotype of nvIBDV was characterized using sequence analysis of segments A and B. Bursal histopathology and statistical analyses were conducted to evaluate the virus's immunosuppressive effects. Results: Infected SPF chickens displayed no clinical signs but showed significant bursal atrophy and lesions across all passages (p < 0.05). Broilers infected with nvIBDV exhibited no mortality or clinical signs; however, ND antibody titers significantly declined by 14 days post-challenge (1493.0 ± 746.1) compared with the unchallenged group (2975.7 ± 189.5; p < 0.01). Histopathological analysis revealed severe depletion of the bursal follicles, lymphoid cell aggregation, necrosis, and hemorrhage. Genotyping of nvIBDV identified as genotype A2dB1, consistent with strains from other regions. Conclusion: The Malaysian nvIBDV strain causes subclinical infections in SPF and broiler chickens, resulting in bursal atrophy and reduced ND vaccine-induced antibody titers. Silent spread and immunosuppressive effects present significant challenges to poultry health management and vaccination efficacy. Enhanced diagnostic and biosecurity measures are crucial for mitigating its impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.